Dataset Information

An artificial intelligence life cycle: From conception to production.

ABSTRACT: This paper presents the "CDAC AI life cycle," a comprehensive life cycle for the design, development, and deployment of artificial intelligence (AI) systems and solutions. It addresses the void of a practical and inclusive approach that spans beyond the technical constructs to also focus on the challenges of risk analysis of AI adoption, transferability of prebuilt models, increasing importance of ethics and governance, and the composition, skills, and knowledge of an AI team required for successful completion. The life cycle is presented as the progression of an AI solution through its distinct phases-design, develop, and deploy-and 19 constituent stages from conception to production as applicable to any AI initiative. This life cycle addresses several critical gaps in the literature where related work on approaches and methodologies are adapted and not designed specifically for AI. A technical and organizational taxonomy that synthesizes the functional value of AI is a further contribution of this article.

SUBMITTER: De Silva D

PROVIDER: S-EPMC9214328 | biostudies-literature | 2022 Jun

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

An artificial intelligence life cycle: From conception to production.

De Silva Daswin D Alahakoon Damminda D

Patterns (New York, N.Y.) 20220413 6

This paper presents the "CDAC AI life cycle," a comprehensive life cycle for the design, development, and deployment of artificial intelligence (AI) systems and solutions. It addresses the void of a practical and inclusive approach that spans beyond the technical constructs to also focus on the challenges of risk analysis of AI adoption, transferability of prebuilt models, increasing importance of ethics and governance, and the composition, skills, and knowledge of an AI team required for succes ...[more]

PMID: 35755876

Similar Datasets

Project description:ObjectiveAlthough artificial intelligence (AI) has demonstrated promise in enhancing breast cancer diagnosis, the implementation of AI algorithms in clinical practice encounters various barriers. This scoping review aims to identify these barriers and facilitators to highlight key considerations for developing and implementing AI solutions in breast cancer imaging.MethodA literature search was conducted from 2012 to 2022 in six databases (PubMed, Web of Science, CINHAL, Embase, IEEE, and ArXiv). The articles were included if some barriers and/or facilitators in the conception or implementation of AI in breast clinical imaging were described. We excluded research only focusing on performance, or with data not acquired in a clinical radiology setup and not involving real patients.ResultsA total of 107 articles were included. We identified six major barriers related to data (B1), black box and trust (B2), algorithms and conception (B3), evaluation and validation (B4), legal, ethical, and economic issues (B5), and education (B6), and five major facilitators covering data (F1), clinical impact (F2), algorithms and conception (F3), evaluation and validation (F4), and education (F5).ConclusionThis scoping review highlighted the need to carefully design, deploy, and evaluate AI solutions in clinical practice, involving all stakeholders to yield improvement in healthcare.Clinical relevance statementThe identification of barriers and facilitators with suggested solutions can guide and inform future research, and stakeholders to improve the design and implementation of AI for breast cancer detection in clinical practice.Key points• Six major identified barriers were related to data; black-box and trust; algorithms and conception; evaluation and validation; legal, ethical, and economic issues; and education. • Five major identified facilitators were related to data, clinical impact, algorithms and conception, evaluation and validation, and education. • Coordinated implication of all stakeholders is required to improve breast cancer diagnosis with AI.

Project description:BackgroundArtificial intelligence (AI) applications are growing at an unprecedented pace in health care, including disease diagnosis, triage or screening, risk analysis, surgical operations, and so forth. Despite a great deal of research in the development and validation of health care AI, only few applications have been actually implemented at the frontlines of clinical practice.ObjectiveThe objective of this study was to systematically review AI applications that have been implemented in real-life clinical practice.MethodsWe conducted a literature search in PubMed, Embase, Cochrane Central, and CINAHL to identify relevant articles published between January 2010 and May 2020. We also hand searched premier computer science journals and conferences as well as registered clinical trials. Studies were included if they reported AI applications that had been implemented in real-world clinical settings.ResultsWe identified 51 relevant studies that reported the implementation and evaluation of AI applications in clinical practice, of which 13 adopted a randomized controlled trial design and eight adopted an experimental design. The AI applications targeted various clinical tasks, such as screening or triage (n=16), disease diagnosis (n=16), risk analysis (n=14), and treatment (n=7). The most commonly addressed diseases and conditions were sepsis (n=6), breast cancer (n=5), diabetic retinopathy (n=4), and polyp and adenoma (n=4). Regarding the evaluation outcomes, we found that 26 studies examined the performance of AI applications in clinical settings, 33 studies examined the effect of AI applications on clinician outcomes, 14 studies examined the effect on patient outcomes, and one study examined the economic impact associated with AI implementation.ConclusionsThis review indicates that research on the clinical implementation of AI applications is still at an early stage despite the great potential. More research needs to assess the benefits and challenges associated with clinical AI applications through a more rigorous methodology.

Dataset Information

An artificial intelligence life cycle: From conception to production.

Publications

An artificial intelligence life cycle: From conception to production.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets